Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
ANI Pharmaceuticals Inc
Swot
ANI Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
ANI Pharmaceuticals Inc has 14 Strengths, 8 Weaknesses, 0 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(14)
Weakness
(8)
Opportunity
(0)
Threats
(2)
Others
(2)
Consistent Highest Return Stocks over Five Years - Nifty500
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Increasing Revenue every Quarter for the past 4 Quarters
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Stocks Outperforming their Industry Price Change in the Quarter
Momentum Trap (DVM)
Companies with High Debt
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Promoters increasing shareholding QoQ
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
